 | • レポートコード：MRC2304I0170 • 出版社/出版日：Persistence Market Research / 2023年1月20日 • レポート形態：英文、PDF、302ページ • 納品方法：Eメール • 産業分類：医療 |
| Single User | ￥725,200 (USD4,900) | ▷ お問い合わせ |
| Site Licence | ￥1,124,800 (USD7,600) | ▷ お問い合わせ |
| Enterprisewide | ￥1,568,800 (USD10,600) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| Persistence Market Research社の本調査資料では、世界の骨誘導再生法（GBR）市場について調査・分析を行い、市場の現状と今後の展望を整理しています。本書は、エグゼクティブサマリー、市場概要、主要市場動向、主要内容、市場背景、新型コロナウイルス感染症危機分析、需要分析・予測、価格分析、材料別（骨移植代替品、隔膜）分析、用途別（インプラント、歯周病、口腔・顎顔面手術、その他）分析、エンドユーザー別（病院、歯科クリニック、学術・研究センター、外来手術センター）分析、地域別（北米、中南米、ヨーロッパ、東アジア、南アジア、オセアニア、中東・アフリカ）分析、市場構造分析、競争分析、仮定、調査手法など、以下の構成で掲載しています。また、Baxter International Inc.、Medtronic、Stryker Corp.、Integra LifeSciences、Zimmer Biomet Holdings、Dentsply Sirona、botiss biomaterials GmbH、Geistlich Pharma AG、Biotech Dental、Dentegris GmbH、GENOSS Co.,Ltd.、Osstem Implantなどの企業情報が含まれています。 ・エグゼクティブサマリー ・市場概要 ・主要市場動向 ・主要内容 ・新型コロナウイルス感染症危機分析 ・需要分析・予測 ・価格分析 ・世界の骨誘導再生法（GBR）市場規模：材料別 - 骨移植代替品の市場規模 - 隔膜の市場規模 ・世界の骨誘導再生法（GBR）市場規模：用途別 - インプラントにおける市場規模 - 歯周病における市場規模 - 口腔・顎顔面手術における市場規模 - その他用途における市場規模 ・世界の骨誘導再生法（GBR）市場規模：エンドユーザー別 - インプラントにおける市場規模 - 病院における市場規模 - 歯科クリニックにおける市場規模 - 学術・研究センターにおける市場規模 - 外来手術センターにおける市場規模 ・世界の骨誘導再生法（GBR）市場規模：地域別 - 北米の骨誘導再生法（GBR）市場規模 - 中南米の骨誘導再生法（GBR）市場規模 - ヨーロッパの骨誘導再生法（GBR）市場規模 - 東アジアの骨誘導再生法（GBR）市場規模 - 南アジアの骨誘導再生法（GBR）市場規模 - オセアニアの骨誘導再生法（GBR）市場規模 - 中東・アフリカの骨誘導再生法（GBR）市場規模 ・市場構造分析 ・競争分析 ・仮定 ・調査手法 |
Guided Bone Regeneration Market: Report Scope
A new publication by Persistence Market Research on the global guided bone regeneration market evaluates the opportunities and current market landscape, provides detailed analysis, and updates about corresponding sections affecting the market. The study offers detailed insights into current market dynamics, which include the drivers, restraints, trends, and opportunities in the market. The principal aim of the market study is to present exclusive information about how the market will perform during the forecast period of 2023 to 2033.
Important indicators for the successful growth of the market are presented in this comprehensive report, which includes a Year-on-Year (Y-o-Y) growth analysis of the market, and compounded annual growth rate (CAGR), which are described exhaustively in Persistence Market Research’s study. This research study can support readers to know the demand for the guided bone regeneration market and the quantitative development opportunities during the study period.
The research is beneficial for shareholders in the landscape, including investors, manufacturers, service providers, distributors, and suppliers, and can help them in developing suitable business strategies to flourish in the guided bone regeneration market. Shareholders in the guided bone regeneration market, industry experts, investors, researchers, and reporters, as well as business enthusiasts, can leverage insights and information presented in this Persistence Market Research study.
Market statistics, as well as information linked to the macro- as well as macroeconomic variables affecting the business scenario in the guided bone regeneration market, are also included in the current study. Depending on potential developments in the market, substantive insights are also encountered in this report. Additionally, by the data submitted in this report, minor companies and new entrants in the industry can be aided in making suitable company choices to achieve traction in the market.
Key Market Segments
Persistence Market Research’s study on the guided bone regeneration market offers information divided into four important segments – material, application, end user, and region. This report offers comprehensive data and information about the important market dynamics and growth parameters associated with these categories.
Material
Bone Graft Substitutes
Allograft
Xenograft
Synthetic Bone Graft
Others
Barrier Membranes
Expanded polytetrafluoroethylene (e-PTFE)
High-density Polytetrafluoroethylene (d-PTFE)
Titanium Mesh and Titanium-reinforced PTFE
Application
Implantology
Periodontology
Oral and Maxillofacial Surgery
Others
End User
Hospitals
Dental Clinics
Academic & Research Centers
Ambulatory Surgical Centers
Region
North America
Latin America
Europe
South Asia
East Asia
Oceania
Middle East and Africa
Key Questions Answered in Report
Which regions will continue to remain the most profitable markets for guided bone regeneration?
How will changing trends affect the market?
How has the COVID-19 crisis affected market growth?
How can market players capture the low-hanging opportunities in developed regions?
What are the strategies of stakeholders in the market to shape their position in this landscape?
What are the restraining factors that investors need to be aware of and might tackle while investing in the market?
What are the developmental trends that will influence the market?
How can companies in the guided bone regeneration market avail themselves the growth opportunities in developed and emerging sectors?
Research Methodology
In Persistence Market Research’s study, a unique research methodology is utilized to conduct extensive research on the growth of the guided bone regeneration market, and reach conclusions on the future growth parameters of the market. This research methodology is a combination of primary and secondary research, which helps analysts to ensure the accuracy and reliability of the conclusions.
Secondary resources referred to by analysts during the materialism of the market study include statistics from governmental organizations, trade journals, white papers, and internal and external proprietary databases. Analysts have interviewed senior managers, material portfolio managers, CEOs, VPs, marketing/material managers, and market intelligence managers, who contributed to the development of this report as a primary resource.
Comprehensive information acquired from primary and secondary resources acts as validation from companies in the market and makes Persistence Market Research’s projections on the growth prospects of the guided bone regeneration market are more accurate and reliable.
レポート目次1. Executive Summary
1.1. Global Market Outlook
1.2. Demand Side Trends
1.3. Supply Side Trends
1.4. Analysis and Recommendations
2. Market Overview
2.1. Market Coverage / Taxonomy
2.2. Market Definition / Scope / Limitations
2.3. Inclusion And Exclusions
3. Key Market Trends
3.1. Key Trends Impacting the Market
3.2. Development Trends
4. Key Inclusions
4.1. Product Adoption Analysis by Region
4.2. Product USP Analysis
4.3. Key Promotional Strategies by Manufacturers
4.4. Regulatory Scenario
4.5. PESTLE Analysis
4.6. Porter’s Analysis
4.7. Value Chain Analysis
5. Market Background
5.1. Macro-Economic Factors
5.1.1. Global GDP Growth Outlook
5.1.2. Global Healthcare Industry Outlook
5.1.3. Global Bone Regeneration Market Overview
5.2. Forecast Factors – Relevance & Impact
5.2.1. Top Companies Historical Growth
5.2.2. Increasing Prevalence of Dental Diseases
5.2.3. Adoption of Minimally Invasive Procedures
5.2.4. Increasing Prevalence of Bone Related disorders
5.2.5. New Product launches and approvals
5.2.6. Regulatory Policies
5.2.7. Historic and Current Revenue of key players
5.2.8. Technology advancements
5.3. Market Dynamics
5.3.1. Drivers
5.3.2. Restraints
5.3.3. Opportunity Analysis
6. COVID-19 Crisis Analysis
6.1. 2021 Market Scenario
6.2. COVID-19 and Impact Analysis
6.2.1. By Material
6.2.2. By Application
6.2.3. By End User
6.2.4. By Region
7. Global Guided Bone Regeneration Market Demand (Volume) Analysis 2017–2022 and Forecast, 2023–2033
7.1. Historical Market Volume (‘000 Units) Analysis, 2017–2022
7.2. Current and Future Market Volume (‘000 Units) Projections, 2023–2033
7.2.1. Y-o-Y Growth Trend Analysis
8. Global Guided Bone Regeneration Market – Pricing Analysis
8.1. Regional Pricing Analysis By Material
8.2. Pricing Break Up
8.2.1. Manufacturer Level
8.2.2. Distributor Level
8.3. Global Average Pricing Analysis Benchmark
8.4. Pricing Assumptions
9. Global Guided Bone Regeneration Market Demand (in Value or Size in US$ Mn) Analysis 2017–2022 and Forecast, 2023–2033
9.1. Historical Market Value (US$ Mn) Analysis, 2017–2022
9.2. Current and Future Market Value (US$ Mn) Projections, 2023–2033
9.2.1. Y-o-Y Growth Trend Analysis
9.2.2. Absolute $ Opportunity Analysis
10. Global Guided Bone Regeneration Market Analysis 2017–2022 and Forecast 2023–2033, By Material
10.1. Introduction / Key Findings
10.2. Historical Market Size (US$ Mn) and Volume (‘000 Units) Analysis By Material, 2017–2022
10.3. Current and Future Market Size (US$ Mn) and Volume (‘000 Units) Analysis and Forecast By Material, 2023–2033
10.3.1. Bone Graft Substitutes
10.3.1.1. Allograft
10.3.1.2. Xenograft
10.3.1.3. Synthetic Bone Graft
10.3.1.4. Others
10.3.2. Barrier Membrane
10.3.2.1. Expanded polytetrafluoroethylene (e-PTFE)
10.3.2.2. High-density polytetrafluoroethylene (d-PTFE)
10.3.2.3. Titanium mesh and titanium-reinforced PTFE
10.4. Market Attractiveness Analysis By Material
11. Global Guided Bone Regeneration Market Analysis 2017–2022 and Forecast 2023–2033, By Application
11.1. Introduction / Key Findings
11.2. Historical Market Size (US$ Mn) Analysis By Application, 2017–2022
11.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Application, 2023–2033
11.3.1. Implantology
11.3.2. Periodontology
11.3.3. Oral and Maxillofacial surgery
11.3.4. Others
11.4. Market Attractiveness Analysis By Application
12. Global Guided Bone Regeneration Market Analysis 2017–2022 and Forecast 2023–2033, By End User
12.1. Introduction / Key Findings
12.2. Historical Market Size (US$ Mn) Analysis By End User, 2017–2022
12.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By End User, 2023–2033
12.3.1. Hospitals
12.3.2. Dental Clinics
12.3.3. Academic & Research Centers
12.3.4. Ambulatory Surgical Centers
12.4. Market Attractiveness Analysis By End User
13. Global Guided Bone Regeneration Market Analysis 2017–2022 and Forecast 2023–2033, By Region
13.1. Introduction
13.2. Historical Market Size (US$ Mn) and Volume (‘000 Units)Analysis By Region, 2017–2022
13.3. Current and Future Market Size (US$ Mn) and Volume (‘000 Units) Analysis and Forecast By Region, 2023–2033
13.3.1. North America
13.3.2. Latin America
13.3.3. Europe
13.3.4. South Asia
13.3.5. East Asia
13.3.6. Oceania
13.3.7. Middle East and Africa
13.4. Market Attractiveness Analysis By Region
14. North America Guided Bone Regeneration Market Analysis 2017–2022 and Forecast 2023–2033
14.1. Introduction
14.2. Historical Market Size (US$ Mn) and Volume (‘000 Units) Analysis By Market Taxonomy, 2017–2022
14.3. Current and Future Market Size (US$ Mn) and Volume (‘000 Units) Analysis and Forecast By Market Taxonomy, 2023–2033
14.3.1. By Country
14.3.1.1. U.S.
14.3.1.2. Canada
14.3.2. By Material
14.3.3. By Application
14.3.4. By End User
14.4. Market Attractiveness Analysis
14.4.1. By Country
14.4.2. By Material
14.4.3. By Application
14.4.4. By End User
14.5. Key Market Participants – Intensity Mapping
14.6. Drivers and Restraints – Impact Analysis
14.7. Country Level Analysis & Forecast
14.7.1. U.S. Guided Bone Regeneration Market
14.7.1.1. Introduction
14.7.1.2. Market Analysis and Forecast by Market Taxonomy
14.7.1.2.1. By Material
14.7.1.2.2. By Application
14.7.1.2.3. By End User
14.7.2. Canada Guided Bone Regeneration Market
14.7.2.1. Introduction
14.7.2.2. Market Analysis and Forecast by Market Taxonomy
14.7.2.2.1. By Material
14.7.2.2.2. By Application
14.7.2.2.3. By End User
15. Latin America Guided Bone Regeneration Market Analysis 2017–2022 and Forecast 2023–2033
15.1. Introduction
15.2. Historical Market Size (US$ Mn) and Volume (‘000 Units) Analysis By Market Taxonomy, 2017–2022
15.3. Current and Future Market Size (US$ Mn) and Volume (‘000 Units) Analysis and Forecast By Market Taxonomy, 2023–2033
15.3.1. By Country
15.3.1.1. Brazil
15.3.1.2. Mexico
15.3.1.3. Argentina
15.3.1.4. Rest of Latin America
15.3.2. By Material
15.3.3. By Application
15.3.4. By End User
15.4. Market Attractiveness Analysis
15.4.1. By Country
15.4.2. By Material
15.4.3. By Application
15.4.4. By End User
15.5. Key Market Participants – Intensity Mapping
15.6. Drivers and Restraints – Impact Analysis
15.7. Country Level Analysis & Forecast
15.7.1. Brazil Guided Bone Regeneration Market
15.7.1.1. Introduction
15.7.1.2. Market Analysis and Forecast by Market Taxonomy
15.7.1.2.1. By Material
15.7.1.2.2. By Application
15.7.1.2.3. By End User
15.7.2. Mexico Portable Multi-Parameter Monitors Market
15.7.2.1. Introduction
15.7.2.2. Market Analysis and Forecast by Market Taxonomy
15.7.2.2.1. By Material
15.7.2.2.2. By Application
15.7.2.2.3. By End User
15.7.3. Argentina Guided Bone Regeneration Market
15.7.3.1. Introduction
15.7.3.2. Market Analysis and Forecast by Market Taxonomy
15.7.3.2.1. By Material
15.7.3.2.2. By Application
15.7.3.2.3. By End User
16. Europe Guided Bone Regeneration Market Analysis 2017–2022 and Forecast 2023–2033
16.1. Introduction
16.2. Historical Market Size (US$ Mn) and Volume (‘000 Units) Analysis By Market Taxonomy, 2017–2022
16.3. Current and Future Market Size (US$ Mn) and Volume (‘000 Units) Analysis and Forecast By Market Taxonomy, 2023–2033
16.3.1. By Country
16.3.1.1. Germany
16.3.1.2. Italy
16.3.1.3. France
16.3.1.4. U.K.
16.3.1.5. Spain
16.3.1.6. BENELUX
16.3.1.7. Russia
16.3.1.8. Nordic Countries
16.3.1.9. Rest of Europe
16.3.2. By Material
16.3.3. By Portability
16.3.4. By Application
16.3.5. By End User
16.4. Market Attractiveness Analysis
16.4.1. By Country
16.4.2. By Material
16.4.3. By Application
16.4.4. By End User
16.5. Key Market Participants – Intensity Mapping
16.6. Drivers and Restraints – Impact Analysis
16.7. Country Level Analysis & Forecast
16.7.1. Germany Guided Bone Regeneration Market
16.7.1.1. Introduction
16.7.1.2. Market Analysis and Forecast by Market Taxonomy
16.7.1.2.1. By Material
16.7.1.2.2. By Application
16.7.1.2.3. By End User
16.7.2. Italy Guided Bone Regeneration Market
16.7.2.1. Introduction
16.7.2.2. Market Analysis and Forecast by Market Taxonomy
16.7.2.2.1. By Material
16.7.2.2.2. By Application
16.7.2.2.3. By End User
16.7.3. France Guided Bone Regeneration Market
16.7.3.1. Introduction
16.7.3.2. Market Analysis and Forecast by Market Taxonomy
16.7.3.2.1. By Material
16.7.3.2.2. By Application
16.7.3.2.3. By End User
16.7.4. U.K. Guided Bone Regeneration Market
16.7.4.1. Introduction
16.7.4.2. Market Analysis and Forecast by Market Taxonomy
16.7.4.2.1. By Material
16.7.4.2.2. By Application
16.7.4.2.3. By End User
16.7.5. Spain Guided Bone Regeneration Market
16.7.5.1. Introduction
16.7.5.2. Market Analysis and Forecast by Market Taxonomy
16.7.5.2.1. By Material
16.7.5.2.2. By Application
16.7.5.2.3. By End User
16.7.6. BENULUX Guided Bone Regeneration Market
16.7.6.1. Introduction
16.7.6.2. Market Analysis and Forecast by Market Taxonomy
16.7.6.2.1. By Material
16.7.6.2.2. By Application
16.7.6.2.3. By End User
16.7.7. Russia Guided Bone Regeneration Market
16.7.7.1. Introduction
16.7.7.2. Market Analysis and Forecast by Market Taxonomy
16.7.7.2.1. By Material
16.7.7.2.2. By Application
16.7.7.2.3. By End User
16.7.8. Nordic Countries Guided Bone Regeneration Market
16.7.8.1. Introduction
16.7.8.2. Market Analysis and Forecast by Market Taxonomy
16.7.8.2.1. By Material
16.7.8.2.2. By Application
16.7.8.2.3. By End User
17. South Asia Guided Bone Regeneration Market Analysis 2017–2022 and Forecast 2023–2033
17.1. Introduction
17.2. Historical Market Size (US$ Mn) and Volume (‘000 Units) Analysis By Market Taxonomy, 2017–2022
17.3. Current and Future Market Size (US$ Mn) and Volume (‘000 Units) Analysis and Forecast By Market Taxonomy, 2023–2033
17.3.1. By Country
17.3.1.1. India
17.3.1.2. Indonesia
17.3.1.3. Malaysia
17.3.1.4. Thailand
17.3.1.5. Rest of South Asia
17.3.2. By Material
17.3.3. By Application
17.3.4. By End User
17.4. Market Attractiveness Analysis
17.4.1. By Country
17.4.2. By Material
17.4.3. By Application
17.4.4. By End User
17.5. Key Market Participants – Intensity Mapping
17.6. Drivers and Restraints – Impact Analysis
17.7. Country Level Analysis & Forecast
17.7.1. India Guided Bone Regeneration Market
17.7.1.1. Introduction
17.7.1.2. Market Analysis and Forecast by Market Taxonomy
17.7.1.2.1. By Material
17.7.1.2.2. By Application
17.7.1.2.3. By End User
17.7.2. Indonesia Guided Bone Regeneration Market
17.7.2.1. Introduction
17.7.2.2. Market Analysis and Forecast by Market Taxonomy
17.7.2.2.1. By Material
17.7.2.2.2. By Application
17.7.2.2.3. By End User
17.7.3. Malaysia Guided Bone Regeneration Market
17.7.3.1. Introduction
17.7.3.2. Market Analysis and Forecast by Market Taxonomy
17.7.3.2.1. By Material
17.7.3.2.2. By Application
17.7.3.2.3. By End User
17.7.4. Thailand Guided Bone Regeneration Market
17.7.4.1. Introduction
17.7.4.2. Market Analysis and Forecast by Market Taxonomy
17.7.4.2.1. By Material
17.7.4.2.2. By Application
17.7.4.2.3. By End User
18. East Asia Guided Bone Regeneration Market Analysis 2017–2022 and Forecast 2023–2033
18.1. Introduction
18.2. Historical Market Size (US$ Mn) and Volume (‘000 Units) Analysis By Market Taxonomy, 2017–2022
18.3. Current and Future Market Size (US$ Mn) and Volume (‘000 Units) Analysis and Forecast By Market Taxonomy, 2023–2033
18.3.1. By Country
18.3.1.1. China
18.3.1.2. Japan
18.3.1.3. South Korea
18.3.2. By Material
18.3.3. By Application
18.3.4. By End User
18.4. Market Attractiveness Analysis
18.4.1. By Country
18.4.2. By Material
18.4.3. By Application
18.4.4. By End User
18.5. Key Market Participants – Intensity Mapping
18.6. Drivers and Restraints – Impact Analysis
18.7. Country Level Analysis & Forecast
18.7.1. China Guided Bone Regeneration Market
18.7.1.1. Introduction
18.7.1.2. Market Analysis and Forecast by Market Taxonomy
18.7.1.2.1. By Material
18.7.1.2.2. By Application
18.7.1.2.3. By End User
18.7.2. Japan Guided Bone Regeneration Market
18.7.2.1. Introduction
18.7.2.2. Market Analysis and Forecast by Market Taxonomy
18.7.2.2.1. By Material
18.7.2.2.2. By Application
18.7.2.2.3. By End User
18.7.3. South Korea Guided Bone Regeneration Market
18.7.3.1. Introduction
18.7.3.2. Market Analysis and Forecast by Market Taxonomy
18.7.3.2.1. By Material
18.7.3.2.2. By Application
18.7.3.2.3. By End User
19. Oceania Guided Bone Regeneration Market Analysis 2017–2022 and Forecast 2023–2033
19.1. Introduction
19.2. Historical Market Size (US$ Mn) and Volume (‘000 Units) Analysis By Market Taxonomy, 2017–2022
19.3. Current and Future Market Size (US$ Mn) and Volume (‘000 Units) Analysis and Forecast By Market Taxonomy, 2023–2033
19.3.1. By Country
19.3.1.1. Australia
19.3.1.2. New Zealand
19.3.2. By Material
19.3.3. By Application
19.3.4. By End User
19.4. Market Attractiveness Analysis
19.4.1. By Country
19.4.2. By Material
19.4.3. By Application
19.4.4. By End User
19.5. Key Market Participants – Intensity Mapping
19.6. Drivers and Restraints – Impact Analysis
19.7. Country Level Analysis & Forecast
19.7.1. Australia Guided Bone Regeneration Market
19.7.1.1. Introduction
19.7.1.2. Market Analysis and Forecast by Market Taxonomy
19.7.1.2.1. By Material
19.7.1.2.2. By Application
19.7.1.2.3. By End User
19.7.2. New Zealand Guided Bone Regeneration Market
19.7.2.1. Introduction
19.7.2.2. Market Analysis and Forecast by Market Taxonomy
19.7.2.2.1. By Material
19.7.2.2.2. By Application
19.7.2.2.3. By End User
20. Middle East and Africa (MEA) Guided Bone Regeneration Market Analysis 2017–2022 and Forecast 2023–2033
20.1. Introduction
20.2. Historical Market Size (US$ Mn) and Volume (‘000 Units) Analysis By Market Taxonomy, 2017–2022
20.3. Current and Future Market Size (US$ Mn) and Volume (‘000 Units) Analysis and Forecast By Market Taxonomy, 2023–2033
20.3.1. By Country
20.3.1.1. GCC Countries
20.3.1.2. Turkey
20.3.1.3. North Africa
20.3.1.4. South Africa
20.3.1.5. Rest of Middle East and Africa
20.3.2. By Material
20.3.3. By Application
20.3.4. By End User
20.4. Market Attractiveness Analysis
20.4.1. By Country
20.4.2. By Material
20.4.3. By Application
20.4.4. By End User
20.5. Key Market Participants – Intensity Mapping
20.6. Drivers and Restraints – Impact Analysis
20.7. Country Level Analysis & Forecast
20.7.1. GCC Countries Guided Bone Regeneration Market
20.7.1.1. Introduction
20.7.1.2. Market Analysis and Forecast by Market Taxonomy
20.7.1.2.1. By Material
20.7.1.2.2. By Application
20.7.1.2.3. By End User
20.7.2. Turkey Guided Bone Regeneration Market
20.7.2.1. Introduction
20.7.2.2. Market Analysis and Forecast by Market Taxonomy
20.7.2.2.1. By Material
20.7.2.2.2. By Application
20.7.2.2.3. By End User
20.7.3. North Africa Guided Bone Regeneration Market
20.7.3.1. Introduction
20.7.3.2. Market Analysis and Forecast by Market Taxonomy
20.7.3.2.1. By Material
20.7.3.2.2. By Application
20.7.3.2.3. By End User
20.7.4. South Africa Guided Bone Regeneration Market
20.7.4.1. Introduction
20.7.4.2. Market Analysis and Forecast by Market Taxonomy
20.7.4.2.1. By Material
20.7.4.2.2. By Application
20.7.4.2.3. By End User
21. Market Structure Analysis
21.1. Market Analysis by Tier of Companies
21.2. Market Share Analysis of Top Players
21.3. Market Presence Analysis
21.3.1. Regional footprint of Players
21.3.2. Material footprint by Players
21.3.3. Channel footprint by Players
22. Competition Analysis
22.1. Competition Dashboard
22.2. Competition Benchmarking
22.3. Competition Deep Dive
22.3.1. Baxter International Inc.
22.3.1.1. Overview
22.3.1.2. Product Portfolio
22.3.1.3. Key Financials by Market Segments (Product/Channel/Region)
22.3.1.4. Sales Footprint
22.3.1.5. SWOT Analysis
22.3.1.6. Key Developments
22.3.1.7. Strategy Overview
22.3.1.7.1. Channel Strategy
22.3.1.7.2. Marketing Strategy
22.3.1.7.3. Material Strategy
22.3.2. Medtronic
22.3.2.1. Overview
22.3.2.2. Product Portfolio
22.3.2.3. Key Financials by Market Segments (Product/Channel/Region)
22.3.2.4. Sales Footprint
22.3.2.5. SWOT Analysis
22.3.2.6. Key Developments
22.3.2.7. Strategy Overview
22.3.2.7.1. Channel Strategy
22.3.2.7.2. Marketing Strategy
22.3.2.7.3. Material Strategy
22.3.3. Stryker Corp.
22.3.3.1. Overview
22.3.3.2. Product Portfolio
22.3.3.3. Key Financials by Market Segments (Product/Channel/Region)
22.3.3.4. Sales Footprint
22.3.3.5. SWOT Analysis
22.3.3.6. Key Developments
22.3.3.7. Strategy Overview
22.3.3.7.1. Channel Strategy
22.3.3.7.2. Marketing Strategy
22.3.3.7.3. Material Strategy
22.3.4. Integra LifeSciences
22.3.4.1. Overview
22.3.4.2. Product Portfolio
22.3.4.3. Key Financials by Market Segments (Product/Channel/Region)
22.3.4.4. Sales Footprint
22.3.4.5. SWOT Analysis
22.3.4.6. Key Developments
22.3.4.7. Strategy Overview
22.3.4.7.1. Channel Strategy
22.3.4.7.2. Marketing Strategy
22.3.4.7.3. Material Strategy
22.3.5. Zimmer Biomet Holdings
22.3.5.1. Overview
22.3.5.2. Product Portfolio
22.3.5.3. Key Financials by Market Segments (Product/Channel/Region)
22.3.5.4. Sales Footprint
22.3.5.5. SWOT Analysis
22.3.5.6. Key Developments
22.3.5.7. Strategy Overview
22.3.5.7.1. Channel Strategy
22.3.5.7.2. Marketing Strategy
22.3.5.7.3. Material Strategy
22.3.6. Dentsply Sirona
22.3.6.1. Overview
22.3.6.2. Product Portfolio
22.3.6.3. Key Financials by Market Segments (Product/Channel/Region)
22.3.6.4. Sales Footprint
22.3.6.5. SWOT Analysis
22.3.6.6. Key Developments
22.3.6.7. Strategy Overview
22.3.6.7.1. Channel Strategy
22.3.6.7.2. Marketing Strategy
22.3.6.7.3. Material Strategy
22.3.7. botiss biomaterials GmbH
22.3.7.1. Overview
22.3.7.2. Product Portfolio
22.3.7.3. Key Financials by Market Segments (Product/Channel/Region)
22.3.7.4. Sales Footprint
22.3.7.5. SWOT Analysis
22.3.7.6. Key Developments
22.3.7.7. Strategy Overview
22.3.7.7.1. Channel Strategy
22.3.7.7.2. Marketing Strategy
22.3.7.7.3. Material Strategy
22.3.8. Geistlich Pharma AG
22.3.8.1. Overview
22.3.8.2. Product Portfolio
22.3.8.3. Key Financials by Market Segments (Product/Channel/Region)
22.3.8.4. Sales Footprint
22.3.8.5. SWOT Analysis
22.3.8.6. Key Developments
22.3.8.7. Strategy Overview
22.3.8.7.1. Channel Strategy
22.3.8.7.2. Marketing Strategy
22.3.8.7.3. Material Strategy
22.3.9. Biotech Dental
22.3.9.1. Overview
22.3.9.2. Product Portfolio
22.3.9.3. Key Financials by Market Segments (Product/Channel/Region)
22.3.9.4. Sales Footprint
22.3.9.5. SWOT Analysis
22.3.9.6. Key Developments
22.3.9.7. Strategy Overview
22.3.9.7.1. Channel Strategy
22.3.9.7.2. Marketing Strategy
22.3.9.7.3. Material Strategy
22.3.10. Dentegris GmbH
22.3.10.1. Overview
22.3.10.2. Product Portfolio
22.3.10.3. Key Financials by Market Segments (Product/Channel/Region)
22.3.10.4. Sales Footprint
22.3.10.5. SWOT Analysis
22.3.10.6. Key Developments
22.3.10.7. Strategy Overview
22.3.10.7.1. Channel Strategy
22.3.10.7.2. Marketing Strategy
22.3.10.7.3. Material Strategy
22.3.11. GENOSS Co.,Ltd.
22.3.11.1. Overview
22.3.11.2. Product Portfolio
22.3.11.3. Key Financials by Market Segments (Product/Channel/Region)
22.3.11.4. Sales Footprint
22.3.11.5. SWOT Analysis
22.3.11.6. Key Developments
22.3.11.7. Strategy Overview
22.3.11.7.1. Channel Strategy
22.3.11.7.2. Marketing Strategy
22.3.11.7.3. Material Strategy
22.3.12. Osstem Implant
22.3.12.1. Overview
22.3.12.2. Product Portfolio
22.3.12.3. Key Financials by Market Segments (Product/Channel/Region)
22.3.12.4. Sales Footprint
22.3.12.5. SWOT Analysis
22.3.12.6. Key Developments
22.3.12.7. Strategy Overview
22.3.12.7.1. Channel Strategy
22.3.12.7.2. Marketing Strategy
22.3.12.7.3. Material Strategy
23. Assumptions and Acronyms Used
24. Research Methodology